Search

Author/Creator Buchbinder, N.

1. ALK INHIBITORS SAFETY PROFILE IN PEDIATRIC PATIENTS TREATED FOR AN ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA: REAL LIFE EXPERIENCE AMONG A FRENCH COHORT. (October 2022)

Authors:
d'Hautefeuille, C.; Abbou, S.; El-Gourari-Miaz, L.; Lambilliotte, A.; Renard, C.; Landman-Parker, J.; Gourdon, S.; Metayer, L.; Leblanc, T.; Pacquement, H.; Rabian, F.; Verschuur, A.; Brasme, J.; Millot, F.; Pagnier, A.; Buchbinder, N.; Rorhlich, P.; Minard-Colin, V.; Brugières, L.; Ducassou, S.
Journal:
Leukemia research
Issue:
Volume 121(2022)Supplement
Page Start:
S68
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. EXCELLENT OUTCOME OF CHILDREN/ADOLESCENTS WITH PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA TREATED WITH LMB-BASED CHEMOTHERAPY WITH RITUXIMAB. (October 2022)

Authors:
Dourthe, M.; Phulpin, A.; Auperin, A.; Couec, M.; Dartigues, P.; Ducassou, S.; Garnier, N.; Haouy, S.; Leblanc, T.; Lambilliotte, A.; Leruste, A.; Jourdain, A.; Spiegel, A.; Rigaud, C.; Simonin, M.; Bonneau, J.; Verschuur, A.; Plat, G.; Poirée, M.; Buchbinder, N.
Journal:
Leukemia research
Issue:
Volume 121(2022)Supplement
Page Start:
S10
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search